Last update July 11, 2017
Very Low Risk
Pro-drug which is metabolized to methimazole that is equivalent to 60% of drug.
Excretion into breast milk is insignificant (Low 1979, Johansen 1972, Rylance 1987).
No adverse effects reported in breastfed infants (Rylance 1987).
Plasma levels in those infants were shown to be very low (Rylance 1987).
Daily dose up to 30 mg has shown to be safe for the infant (Lamberg 1984, Verd 1998, Bartalena 2005) at both short term (hormone serum level) and long term (psychomotor development).follow-up.
The American Academy of Pediatrics rates us as compatible with breastfeeding
We do not have alternatives for Carbimazole since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM